Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

24-hour ECG Holter monitoring and Dobutamine-echocardiography in patients suffering from stenocardia with exercise ECG test contraindications

Jerzy K. Wranicz, Mariusz Strzondała, M. Maciejewski, J. Ruta, H. Bolińska

Med Sci Monit 1999; 5(5): CR915-919 :: ID: 503413

Abstract

The aim of this study was to assess the usefulness of 24-hour ECG Holter monitoring (HM) and Dobutamine Echo (DE) performed simultaneously in the detection of patients suffering from stenocardia who demonstrate significant coronary artery changes.We retrospectively analysed a group of 71 pts (56 M, 15 W, aged between 42 and 59 years, mean 51±6), with the Leriche syndrome or an abdominal aorta aneurysm (exercise test contraindications), suffering from stenocardia that were qualified for coronarography. All patients demonstrated standard ECG ischemic changes and were qualified for different vascular surgical procedures. 39 pts presented with significant coronary artery stenosis (at least 75%): 3 vessels - 6 pts, 2 vessels - 14 pts, 1 vessel - 19 pts. Prior to coronarography we performed HM and DE simultaneously.We compared both non-invasive method results separately and together with coronarographic findings. The sensitivity, specificity, positive predictive value, negative predictive value and test accuracy of Dobutamine Echo were 80, 94, 94, 79, 86%, respectively that of Holter monitoring 62, 72, 68, 72, 70%, respectively and together 92, 81, 86, 90, 87%, respectively.
Conclusion: HM and DE performed simultaneously increase the detectability of patients with the Leriche syndrome or an abdominal aorta aneurysm that demonstrates significant coronary artery changes.

Keywords: Dobutamine-echocardiography, 24-hour ECG monitoring, Leriche syndrome, stenocardia, abdominal aorta aneurysm

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750